Market Access News | pharmaphorum

News

Medical groups, federal staffers call for RFK Jr to resign

The call for HHS Secretary Kennedy to resign is fast becoming a clamour, as medical, public health and patient groups, and federal employees chime in.

News

Eisai moves swiftly to expand subcutaneous Leqembi label

Before it has even launched, Eisai has filed to widen subcutaneous Leqembi's label to include starting as well as maintenance dosing in Alzheimer's.

News

A vaccine adcomm expert criticised RFK Jr – now he's out

A prominent critic of RFK Jr's approach to vaccination regulation, Dr Paul Offit, has been removed from an influential FDA advisory committee.

News

Ex-CDC chiefs sound alarm bells over HHS under Kennedy

No fewer than nine former directors of the CDC have said every American should be alarmed at what is happening on HHS Secretary Kennedy's watch.

News

Prof Dawn Craig, director of the Observatory

Uni wins big NIHR grant for healthtech 'horizon scanning'

A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.

News

Sanofi breaks new ground for BTK drugs with ITP approval

Sanofi's BTK inhibitor Wayrilz has become the first drug in the class to be approved for rare platelet-busting disease immune thrombocytopenia.

Medical groups, federal staffers call for RFK Jr to resign

Eisai moves swiftly to expand subcutaneous Leqembi label

A vaccine adcomm expert criticised RFK Jr – now he's out

Ex-CDC chiefs sound alarm bells over HHS under Kennedy

Uni wins big NIHR grant for healthtech 'horizon scanning'

Sanofi breaks new ground for BTK drugs with ITP approval

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks